JACKSONVILLE, Fla. - A groundbreaking new study is underway at Mayo Clinic Jacksonville that’s being compared to the discovery of penicillin.
A group of 140 women will take part in a breast cancer genome-guided therapy called B.E.A.U.T.Y.
"Everyone is made up of genes, it's like a code and it's trying to figure out what everyone’s code is,“ Dr. Sarah McLaughlin said.
Sheryl Rodgers, an engineer with the Jacksonville Fire and Rescue Department, said after learning she has breast cancer, she feared for her daughter.
"I knew possibly my daughter would be at risk and family members. I thought maybe this will help them discover other treatments." she says.
McLaughlin said the study could lead to treatments that are tailor made for each patient. Better treatments mean a better outcome.
"This is the wave of the future, drugs that are gen-targeted and marker targeted and unique to individual people,” she said.
Donations from the upcoming Pink Ribbon Golf Classic on Oct. 16 at the Ponte Vedra Inn & Club are helping to fund the participation of some of the woman taking part in the mayo study. For more information about the tournament registration, other PRGC events and sponsorship information, visit www.PinkRibbonJax.org.